Swedish firm readies image-guided radiotherapy device
This article was originally published in Clinica
Executive Summary
Elekta predicts that its latest device for simultaneously imaging and treating cancer will be on the market worldwide in 18 month's time and has begun selling an up-gradable platform in preparation. The Swedish company is currently finalising development and testing of the imaging system, which can treat cancers anywhere in the boy, in four hospitals in Europe and North America.